Effect of Mitomycin-C on Endothelial Cell Density and Polymegathism in Laser Assisted Sub-Epithelial Keratectomy
Journal of Ophthalmic and Optometric Sciences,
Vol. 1 No. 1 (2016),
6 October 2016
,
Page 7-13
https://doi.org/10.22037/joos.v1i1.14312
Abstract
Purpose: To evaluate the corneal endothelial cell density and Polymegathism after laser assisted keratomileusis with mitomycin C.
Patients and Methods: One hundred and three eyes from 52 patients undergoing laser assisted sub-epithelial keratomileusis using mitomycin-C 0.02% for 30 seconds entered this study. Specular microscopy was utilized to study the corneal endothelial cells before and one year after the surgery to evaluate the endothelial cell density and polymegathism. The corneal thickness was measured before and one year after the surgery.
Results: The mean endothelial cell density before surgery was 2870±368/mm2, which changed to 2828±300/mm2 one year after the surgery (P=0.182). Endothelial cell size variation coefficient was 24±7 before the surgery, which changed to 25±7 one year after the surgery (P=0.039). The average stromal ablation dept was 65 micron (22 to 131 micron) and the remaining corneal thickness one year after the surgery was 488±42 micron (405 to 567 micron) (p<0.001).
Conclusion: Using mitomycin C (0, 02% for 30 seconds) during the laser assisted sub-epithelial keratomileusis did not significantly change the corneal endothelial cell density one year after the surgery but the change in polymegathism was significant.- Laser Assisted Sub-Epithelial Keratectomy
- Mitomycin-C
- Corneal Endothelial Cell
- Photorefractive Surgery
- Polymegathism.
How to Cite
References
- Pallikaris IG, Siganos DS. Excimer laser in situ keratomileusis and photorefractive keratectomy for the correction of high myopia. J Refract Corneal Surg. 1994;10(5):498-510.
- Camellin M. What about LASEK? J Refract Surg. 2008;24(5):462.
- Shojaei A, Mohammad-Rabei H, Eslani M, Elahi B, Noorizadeh F. Long-Term Evaluation of Complications and Results of Photorefractive Keratectomy in Myopia: An 8-Year Follow-Up. Cornea 2009; 28(3):304-10.
- O’Connor J, O’Keeffe M, Condon PI. Twelve-year follow-up of photorefractive keratectomy for low to moderate myopia. J Refract Surg 2006; 22(9):871-7.
- Taneri S, Feit R, Azar DT. Safety, efficacy, and stability indices of LASEK correction in moderate myopia and astigmatism. J Cataract Refract Surg 2004; 30(10):2130-7.
- Patel SV, Bourne WM . Corneal endothelial cell loss 9 years after excimer laser keratorefractive surgery. Arch Ophthalmol. 2009; 127(11):1423-7.
- Carones F, Brancato R, Venturi E, Vigo L. The human corneal endothelium after myopic excimer laser photorefractive keratectomy immediate to one- month follow- up, Eur J Ophthalmol. 1995; 5(4):204-13.
- Talamo JH, Gollamudi S, Green WR, De La Cruz Z, Filatov V, Stark WJ. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol. 1991; 109(8):1141-6.
- Gambato C, Ghirlando A, Moretto E, Busato F, Midena E. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology 2005; 112(2):208-18.
- Jones SS, Azar RG, Cristol SM, Geroski DH, Waring GO 3rd, Stulting RD, et al. Effects of laser in situ keratomileusis (LASIK) on the corneal endothelium. Am J Ophthalmol. 1998; 125(4):465-71.
- Kent DG, Solomon KD, Peng Q, Whiteside SB, Brown SJ, Apple DJ. Effect of surface photorefractive keratectomy and laser in situ keratomileusis on the corneal endothelium. J Cataract Refract Surg. 1997; 23(3):386-97.
- Sadeghi HM, Seitz B, Hayashi S, LaBree L, McDonnell PJ. In vitro effects of mitomycin- C on human keratocytes. J Refract Surg 1998; 14(5):534-40.
- Kim TI, Lee SY, Pak JH, Tchah H, Kook MS. Mitomycin C.ceramide, and 5-fluorouracil inhibit corneal haze and apoptosisafter PRK. Cornea 2006; 25(1):55-60.
- Kim T-I, Pak JH, Lee SY, Tchah H. Mitomycin C induced reduction of keratocytes and fibroblasts after photorefractive keratectomy. Invest Ophthalmol Vis Sci 2004; 45(9):2978-84.
- Shojaei A, Ramezanzadeh M, Soleyman-Jahi S, Almasi-Nasrabadi M, Rezazadeh P, Eslani M. Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia. J Cataract Refract Surg. 2013;39(2):197-203.
- Zare M, Jafarinasab MR, Feizi S, Zamani M. The effect of mitomycin-C on corneal endothelial cells after photorefractive keratectomy. J Ophthalmic Vis Res. 2011;6(1):8-12.
- Gambato C, Miotto S, Cortese M, Ghirlando A, Lazzarini D, Midena E. Mitomycin C-assisted photorefractive keratectomy in high myopia: a long-term safety study. Cornea. 2011;30(6):641-5.
- Pérez-Santonja JJ, Sahla HF, Alió JL. Evaluation of endothelical cell changes 1 year after excimer laser in situ keratomileusis.Arch Ophthalmol. 1997; 115(7):841-6.
- Collins MJ, Carr JD, Stulting RD, Azar RG, Waring GO, Smith RE, et al. Effects of laser in situ keratomileusis (lasik) on the corneal endothelium 3 years postoperatively.Am J Ophthalmol. 2001; 131(1):1-6.
- Zhao LQ, Wei RL, Ma XY, Zhu H. Effect of intraoperative mitomycin-C on healthy corneal endothelium after laser-assisted subepithelial keratectomy. J Cataract Refract Surg. 2008; 34(10):1715-9.
- Goldsberry DH, Epstein RJ, Majmudar PA, Epstein RH, Dennis RF, Holley G, et al. Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg. 2007; 23(7):724-7.
- Morales AJ, Zadok D, Mora-Retana R, Martínez-Gama E, Robledo NE, Chayet AS. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol. 2006; 142(3):400-4.
- Nassiri N, Farahangiz S, Rahnavardi M, Rahmani L, Nassiri N. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial, J Cataract Refract Surg. 2008;34(6):902-8.
- Seiler T. Current evaluation of myopia correction with the excimer laser.
Ophthalmologe. 1995;92(4):379-84.
- Hashemi H, Taheri SM, Fotouhi A, Kheiltash A. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a Prospective Clinical Study. BMC Ophthalmol.2004;14:4-12.
- Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral Melt After Pterygium Surgery Using a Single Intraoperative Application of Mitomycin-C. Cornea: 1996;15(5):537-40.
- Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99(11):1647-54.
- Wells AP, Cordeiro MF, Bunce C, Khaw PT. Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology. 2003;110(11):2192-7.
- Khong JJ, Muecke J. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol. 2006; 90(7):819-22.
- Roh DS, Funderburgh JL. Impact on the corneal endothelium of mitomycin C during photorefractive keratectomy. J Refract Surg. 2009; 25(10):894-7.
- Lee DH, Chung HS, Jeon YC, Boo SD, Yoon YD, Kim JG. Photorefractive keratectomy with intraoperative mitomycin-C application. J Cataract Refract Surg 2005; 31(12):2293-8.
- Diakonis VF, Pallikaris A, Kymionis GD, Markomanolakis MM. Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin. Am J Ophthalmol 2007;144(1):99-103.
- Abstract Viewed: 335 times
- PDF Downloaded: 169 times